» Articles » PMID: 15513540

Laryngeal Paraganglioma: an Updated Critical Review

Overview
Date 2004 Oct 30
PMID 15513540
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Laryngeal paragangliomas are rare submucosal lesions that arise from paraganglion cells located in the false vocal fold and subglottic larynx. To date, 76 recognized cases have been reported in the world literature. Symptoms arise when the lesions become large enough to impair function. Supraglottic paragangliomas cause hoarseness and deglutition disorders, whereas subglottic tumors become symptomatic when they obstruct the airway. Evaluation of these tumors includes obtaining a complete history. Familial paragangliomas and hypertension should be sought but are rarely, if ever, associated with laryngeal paragangliomas. MRI can detect these lesions and permit characterization of the vascularity of the lesion. Adding 111In pentetreotide scanning can distinguish neuroendocrine tumors from other submucosal laryngeal lesions, making the preoperative diagnosis clearer and obviating the need for biopsy. The biggest dilemma regarding laryngeal paragangliomas is making the correct pathologic distinction between paraganglioma, typical carcinoid, atypical carcinoid and medullary thyroid cancer. Immunohistochemical markers, supplementing standard histopathologic evaluation, can distinguish paragangliomas from the aforementioned tumors. This distinction is critical as the prognosis for treated paragangliomas is excellent compared to that for other neuroendocrine neoplasms. Almost all alleged malignant paragangliomas of the larynx are in reality atypical carcinoid tumors that have been misdiagnosed. Treatment should always comprise excision. Thyrotomy has the best chance of achieving a sustained cure without damaging phonation or deglutition. Laser excision has been used successfully but there is no great experience with this modality. Surgery is preferable to radiation for paragangliomas in all locations but especially so in the larynx, due to issues such as swelling, airway protection and destruction of cartilage. With increased clinical suspicion and the use of modern imaging techniques, laryngeal paragangliomas should be routinely diagnosed and treated without loss of laryngeal functions.

Citing Articles

Random survival forest predicts survival in patients with metastatic laryngeal and hypopharyngeal cancer and the prognostic benefits of surgery and radiotherapy.

Wang Y, Li C, Yang F, Gong M, Qu J, Ma R J Cancer. 2025; 16(2):603-621.

PMID: 39744488 PMC: 11685675. DOI: 10.7150/jca.103793.


Paragangliomas of the head and neck: a contemporary review.

Graham N, Smith J, Else T, Basura G Endocr Oncol. 2023; 2(1):R153-R162.

PMID: 37435464 PMC: 10259325. DOI: 10.1530/EO-22-0080.


Primary Neuroendocrine Carcinoma of the Larynx: A Case Report.

Divya G, Jayamohanan H, Smitha N, Anoop R, Nambiar A, Krishnakumar T Indian J Otolaryngol Head Neck Surg. 2022; 74(Suppl 2):2149-2152.

PMID: 36452826 PMC: 9702140. DOI: 10.1007/s12070-020-02060-z.


Supraglottic Laryngeal Paraganglioma: A Rare Case Report.

Ranjan K, Sah V, Khemka S, Shenoy A Indian J Otolaryngol Head Neck Surg. 2022; 74(Suppl 2):1854-1856.

PMID: 36452630 PMC: 9702037. DOI: 10.1007/s12070-020-01871-4.


Operative technique in laryngeal paraganglioma: A case series and literature review.

Ananthapadmanabhan S, Jabbour J, Tseros E, Sivapathasingam V, Smith M, Riffat F Laryngoscope Investig Otolaryngol. 2022; 7(2):467-475.

PMID: 35434328 PMC: 9008153. DOI: 10.1002/lio2.760.